UV-B irradiation attenuates dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study

Dermatol Surg. 2007 Jan;33(1 Spec No.):S92-6. doi: 10.1111/j.1524-4725.2006.32338.x.

Abstract

Background: Botulinum toxin type A (BoNT/A) is frequently used for cosmetic indications and hyperhidrosis.

Objectives: We investigated whether UV-B irradiation alleviates the BoNT/A effect on local sudomotor activity.

Materials and methods: In a randomized, double-blinded trial, the anhidrotic areas after BoNT/A (100 mU) injection 48 hours before and 14 days after UV-B irradiation were compared in six healthy volunteers.

Results: UV-B irradiation alleviated BoNT/A effect by approximately 30% (p=.0017). The UV-B-evoked reduction of anhidrotic areas was constant over the observation period of 14 weeks.

Conclusions: When BoNT/A is applied intradermally, excessive exposure to UV-B and sunburn should be reconsidered. The authors have indicated no significant interest with commercial supporters.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Botulinum Toxins, Type A* / administration & dosage
  • Botulinum Toxins, Type A* / pharmacology
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Neuromuscular Agents* / administration & dosage
  • Neuromuscular Agents* / pharmacology
  • Ultraviolet Rays* / adverse effects

Substances

  • Botulinum Toxins, Type A
  • Neuromuscular Agents